Bioventus INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Bioventus Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 3, 2026, to elect directors and ratify the appointment of its independent auditor.
NASDAQ
Bioventus Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Bioventus Inc. will hold its annual stockholder meeting virtually on June 3, 2025, to vote on the election of directors and the ratification of its independent accounting firm.
NASDAQ
Bioventus Inc. has engaged Morrow Sodali LLC to solicit proxies for its upcoming Annual Meeting of Stockholders to be held on June 11, 2024.
NASDAQ
Bioventus Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
DEF 14A: Bioventus Inc. Proposes Board Declassification and Director Elections at 2024 Annual Meeting
Bioventus Inc. is seeking stockholder approval for a charter amendment to declassify its Board of Directors and elect directors at the upcoming Annual Meeting on June 11, 2024.